PKPavel S. Kyzlasov

Pavel S. Kyzlasov

*This is an algorithmically generated author record based on publicly available information.

Pavel S. Kyzlasov has a total of 204 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Simultaneous penile prothesis implantation during radical prostatectomy in patients with localized prostate cancer and erectile dysfunction

    by M. V. Shamin, P. S. Kyzlasov, I. V. Kuzmin, A. I. Bragin-Maltsev, E. V. Volokitin, A. K. Gural, М. В. Шамин, П. С. Кызласов, И. В. Кузьмин, А. И. Брагин-Мальцев, et al.

    Introduction. Prostate cancer (PCa) is one of the most common malignancies in middle-aged and older men, ranking second in incidence and sixth in cancer-related mortality worldwide. Among radical treatment options for localised PCa, radical prostatectomy (RP) remains the preferred approach. Objective. To review the current literature on simultaneous penile prosthesis implantation at the time of radical prostatectomy in patients with localised prostate cancer and erectile dysfunction (ED). Materials and methods. A systematic literature search was performed using both international and Russian databases, including Medline, Scopus, Web of Science, PubMed, and eLibrary, to identify rel-evant studies for this review. Results. The review focused on three key aspects: (1) the pathogenesis of erectile dysfunction follow-ing radical prostatectomy; (2) contemporary management strategies for post-prostatectomy ED; and (3) the rationale, techniques, and outcomes of simultaneous penile prosthesis implantation during radical prostatectomy in patients with concomitant PCa and ED. Conclusion. Simultaneous penile prosthesis implantation at the time of radical prostatectomy may rep-resent a preferred option in patients for whom nerve-sparing techniques are contraindicated for onco-logical reasons, offering an effective and safe approach to restoring erectile function. This strategy may also be particularly beneficial in highly motivated patients seeking to preserve penile length.

  • Open Access

    The effect of shock wave therapy on endothelial function and cavernous blood flow: Doppler ultrasonography with functional tests

    by Konstantin A. Burdin, Бурдин Константин Александрович, Pavel S. Kyzlasov, Кызласов Павел Сергеевич

    Aim. To evaluate the effect of low-intensity extracorporeal shock wave therapy (Li-ESWT) on endothelial function of the cavernosal arteries and penile blood flow in men with vasculogenic erectile dysfunction (ED) using Doppler ultrasonography with pharmacological stimulation. Materials and methods. This single-center prospective study included 48 men aged 18–65 years with chronic vasculogenic ED and cardiovascular risk factors, including arterial hypertension (52%), dyslipidemia (42%), obesity (31%), and type 2 diabetes mellitus (21%). Focused Li-ESWT was applied (2000 pulses/session, ~0.10 mJ/mm², 3–5 Hz, twice weekly) for 6–12 sessions targeting the penile shaft and crura. Treatment efficacy was evaluated by Duplex Doppler ultrasonography with intracavernosal alprostadil (10 µg) stimulation using (PSV – peak systolic velocity, EDV – end-diastolic velocity, RI – resistance index) and by International Index of Erectile Function (IIEF-5) at baseline, 1 month, and up to 6 months after therapy. Results. Significant improvement in cavernous hemodynamics was observed: PSV increased from 21.4±8.7 to 32.8±11.5 cm/s (p 0.001), EDV decreased from 6.2±3.1 to 4.0±2.5 cm/s (p=0.01), and RI increased from 0.71±0.11 to 0.86±0.08 (p 0.001). Mean IIEF-5 score improved from 11.8±4.5 to 17.2±5.0 (p 0.001), with clinically meaningful improvement (≥4 points) observed in 62.5% of patients; 21% of those with moderate ED achieved normal erectile function. Patients without severe atherosclerosis of cavernosal arteries demonstrated the most pronounced response, whereas long-standing diabetes and advanced vascular changes were associated with reduced treatment efficacy. No adverse events were recorded. Two clinical cases illustrate a complete response in moderate ED and a partial response in diabetic atherosclerotic ED. Conclusion. Li-ESWT significantly enhances endothelial function and penile blood flow in vasculogenic erectile dysfunction, confirmed by objective Doppler parameters and clinical scores. The best outcomes occur in patients with preserved vascular reserve, whereas severe structural vascular disease may require combined or repeated regenerative interventions. Standardized protocols and long-term prospective studies are warranted.

  • Open Access

    Results of a multicenter prospective study on the efficacy of non-surgical treatment for Peyronie’s disease

    by P. S. Kyzlasov, A. S. Al-Shukri, E. S. Gubanov, M. R. Kolomijceva

    BACKGROUND : Despite advances in medicine, conservative treatment of Peyronie’s disease (PD) remains challenging due to an incomplete understanding of its pathogenesis and limited evidence base, often necessitating surgical intervention. AIM : To evaluate the efficacy and safety of the combined use of Peyroflex® capsules and gel on PD symptoms (pain, penile curvature, fibrous plaque size). METHODS : A prospective comparative cohort study was conducted involving 82 patients with acute-phase PD. Participants were randomized into to 4 groups: 1) Peyroflex® capsules and gel; 2) Peyroflex® Gel + shock wave therapy (SWT); 3) Peyroflex® capsules + gel + SWT; 4) SWT (control group). The follow-up period was 6 months. Primary endpoints included changes in penile curvature (degrees), fibrous plaque area (mm2), and pain intensity measured by Visual Analogue Scale (scores). RESULTS : Combination therapy with Peyroflex® line products (Group 1) demonstrated a statistically significant reduction in plaque area (from 88.7 to 69.6 mm2; p CONCLUSION : The use of Peyroflex® line products, especially in combination with SWT, demonstrates high clinical efficacy in the treatment of acute-phase PD, leading to regression of fibrous plaque and curvature. Therapy with Peyroflex® line products alone also represents an effective conservative treatment option.

  • Psychoemotional status and quality of life of patients after radical prostatectomy depending on the methods of treatment of erectile dysfunction

    by Evgeny V. Pomeshkin, Pavel S. Kyzlasov, Eugeniy V. Volokitin, Boris A. Neymark

    BACKGROUND: Given the high efficacy of medical treatment for erectile dysfunction, active discussions continue regarding the optimal timing for prosthesis implantation after radical prostatectomy. Aim: This study aimed to compare the efficacy of early surgical and conservative treatment of erectile dysfunction in patients after radical prostatectomy. Methods: The study included 53 patients with erectile dysfunction who had undergone radical prostatectomy for localized prostate cancer. All patients began taking phosphodiesterase type 5 inhibitors immediately after surgery. The main group (n = 19) consisted of patients with insufficient efficacy of medical therapy for erectile dysfunction, who underwent penile prosthesis implantation within 1 year after radical prostatectomy, but not earlier than 3 months post-surgery. Patients in the control group (n = 34) continued conservative therapy. At 3 months, 1 year, and 1.5 years after radical prostatectomy, patients were assessed for erectile function using the IIEF-5 questionnaire, quality of life using the SF-36 questionnaires, and levels of anxiety and depression using the Beck and Spielberger–Hanin questionnaires. Results: Analysis of psychoemotional status over time at 1 year after radical prostatectomy showed that patients in the prosthesis group had significantly lower depression scores (p = 0.001) and reactive anxiety (p = 0.03) compared to patients in the control group. This trend between the patient groups persisted at 1.5 years (p = 0.001). The quality of life of patients after prosthesis implantation was also higher at 1 year after radical prostatectomy compared with the control group. This trend between the groups also persisted at 1.5 years. The study data demonstrated that prosthesis implantation significantly improved patients’ erectile function, assessed by IIEF-5, unlike patients in the control group. Conclusion: Penile prosthesis implantation within a year after radical prostatectomy in patients with severe erectile dysfunction is an effective and safe alternative for treating erectile dysfunction as the primary method after 3 months of ineffective medical treatment, with a good level of patient satisfaction and improvement in their psychoemotional status and quality of life.

  • Comparative analysis of surgical techniques for the treatment of varicocele.

    by P.S. Kyzlasov, G.G. Abuev, A.T. Mustafayev

    Introduction. Varicocele is one of the leading causes of male infertility. Despite the availability of various surgical techniques, the optimal approach remains controversial due to differences in recurrence rates, complications, and recovery time. Objective. To compare the effectiveness of laparoscopic varicocelectomy, microsurgical subinguinal varicocelectomy, and an original minimally invasive surgical technique for varicocele treatment. Materials and methods. A prospective randomized single-center study included 120 patients with grade I–III left-sided varicocele, divided into three equal groups. Surgical time, length of hospital stay (LOS), postoperative pain (VAS), complication and recurrence rates, and spermogram parameters were assessed. Follow-up lasted up to 24 months. Results. The original technique was characterized by a significantly shortest operative time – 14±2 min vs to 45±4 min for microsurgery and 50±5 min for laparoscopic ligation (p<0.001). The LOS was 1,1±0,3 days, also statistically significantly shorter than in other groups. The 24-month recurrence rate for the original technique and microsurgery was comparable (2,5% each) and significantly lower than after laparoscopic ligation (10,0%; p<0.05). Pain intensity after 2 weeks was minimal in the original technique group – 3.4±0.8 points on VAS (p<0.01). At the 6-month follow-up, improvement in semen parameters (concentration, motility, morphology) in the microsurgery and original technique groups was significantly more pronounced than after laparoscopic ligation (p<0.001). Conclusion. The original minimally invasive technique is an effective and safe alternative to microsurgical varicocelectomy, providing comparable clinical and functional outcomes with reduced operative time and hospitalization.

  • Penile prosthesis in patients who have undergone radical prostatectomy with erectile dysfunction and mild urinary incontinence

    by A. I. Bragin-Maltsev, P. S. Kyzlasov, K. A. Burdin, A. T. Mustafayev, E. V. Volokitin, V. V. Khvorov

    Introduction. Prostate cancer ranks as the second most prevalent malignancy among men worldwide, with radical prostatectomy (RP) remaining the gold standard treatment for localized disease. However, postoperative complications including erectile dysfunction (ED) and urinary incontinence significantly impair patients’ quality of life. While penile prosthesis implantation is well-established for ED management, its potential role in addressing concomitant urinary incontinence requires further investigation. Aim. To evaluate the effect of implantation of a semi-rigid penile prosthesis on urinary incontinence after RP. Objective. The prospective study included 26 patients who underwent RP without nerve-sparing, with ED (> 1 year) and mild-moderate stress urinary incontinence (urine loss 33–98 g/day according to 24-hour pad test). Exclusion criteria: severe incontinence, cancer recurrence, inflammatory diseases. All patients underwent penoscrotal implantation of a semirigid penile prosthesis. The main efficacy assessment included the pad test, ICIQ-SF, I-QoL, IIEF-5 questionnaires Results: In the group of patients with mild incontinence (< 50 g/day, n = 17), full continence was achieved (0 g according to the pad test) with an improvement in I-QoL indices from 76.9% to 90.2%. In the group with moderate incontinence (50–200 g/day, n = 9), a decrease in urine loss to 74.8 g/day was noted with an increase in I-QoL from 57.5 to 67.8%. Despite the restoration of erectile function in all patients, a decrease in sexual desire associated with residual urine leakage persisted in the second group. No postoperative complications were observed. Conclusion: Penile prosthesis implantation effectively manages mild post-RP incontinence, enabling complete sexual rehabilitation and significant quality-of-life improvement (I-QoL >90%). For moderate incontinence, combined approaches with anti-incontinence procedures (artificial urinary sphincter/sling) are recommended.

  • PENILE REINNERVATION IN PATIENTS WITH ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY (LITERATURE REVIEW)

    by А.K. Gural, P.S. Kyzlasov, Е.V. Volokitin, А.т. Mustafaev, М.V. Shamin, А.V. Leonenko, V.е. Volokitin, D.V. Pashkovskii, Е.N. Ryzhkova, V.S. Boshchenko, et al.

    Introduction. Erectile dysfunction after radical prostatectomy remains one of the most common and clinically significant complications of surgical treatment for prostate cancer, significantly reducing patients’ quality of life. Despite advances in nerve-sparing surgical techniques, erectile function remains incomplete in a significant proportion of men. Therefore, in recent decades, interest in active surgical rehabilitation methods, particularly penile reinnervation procedures using autologous nerve grafts, has increased. Aim of the research. To perform a systematic analysis of the literature data on the development, effectiveness and safety of surgical methods of penile reinnervation using autologous peripheral nerve transplantation in patients after radical prostatectomy. Materials and methods. A systematic search and analysis of scientific publications was performed in the international MEDLINE (PubMed) database, as well as in the Russian electronic resources eLIBRARY.ru and CyberLeninka.ru. The search was carried out using keywords reflecting the issues of erectile dysfunction after radical prostatectomy, surgical reinnervation, and peripheral nerve transplantation. Reference lists of relevant studies were also analyzed. No restrictions were placed on the year of publication or type of study. Results. A literature review revealed that penile reinnervation techniques using sural nerve interposition have been used since the late 1990s and have yielded inconsistent, but in some studies, clinically significant results. Depending on the surgical technique, transplantation laterality, patient age, and the extent of neurovascular bundle resection, restoration of erection sufficient for sexual intercourse was observed in 30-60% of patients. Unilateral nerve transplantation combined with contralateral nerve sparing has been shown to demonstrate more favorable functional outcomes. Modern modifications of the method include laparoscopic and robotic-assisted techniques, as well as somatic-autonomic neurorrhaphy; these approaches are aimed at improving the accuracy of reconstruction and reducing surgical trauma. Conclusion. Surgical penile reinnervation using autologous nerve grafts represents a promising treatment option for iatrogenic erectile dysfunction in patients following radical prostatectomy. Despite positive results from individual studies, the technique remains technically challenging and requires further study in large, prospective, long-term follow-up studies to determine optimal indications, performance standards, and objective assessment of long-term functional outcomes.

  • THE EFFECT OF SIMULTANEOUS PHALLOPLASTY DURING RADICAL PROSTATECTOMY ON THE QUALITY OF LIFE OF PATIENTS WITH PROSTATE CANCER AND CONCOMITANT ERECTILE DYSFUNCTION

    by Mikhail V. Shamin, Pavel S. Kyzlasov, Evgeny V. Volokitin, Evgeniya A. Kameneva, Vladimir V. Pavlenko, Arkady A. Osintsev

    Introduction. Along with a significant increase in the life expectancy of patients after radical prostatectomy, there is also a growing demand for better functional outcomes and quality of life in the long-term postoperative period. While surgical treatments that preserve vascular and neural structures are now widely available for patients with localized prostate cancer without concomitant erectile dysfunction, for patients with a combination of prostate cancer and existing erectile dysfunction, the only option for returning to sexual activity is the insertion of a penile prosthesis. In view of this, there is an urgent question about simultaneous methods of one-stage phalloplasty during radical prostatectomy in patients with localized prostate cancer and existing concomitant erectile dysfunction, which allows the patient to be cured of two diseases in one surgical stage and significantly improve the quality of life in the early postoperative period. Objective. The purpose of this study is to evaluate the impact of simultaneous phalloplasty during radical prostatectomy on the quality of life in patients with localized prostate cancer and concomitant erectile dysfunction. Materials and Methods. A prospective analysis of 60 patients with localized prostate cancer and concomitant erectile dysfunction was conducted. The patients were divided into two groups of 30 patients each. The first group consisted of patients who agreed to the simultaneous placement of a penile endoprosthesis during prostatectomy, while the second group consisted of patients who refused the simultaneous placement of a penile prosthesis during radical prostatectomy. Group I patients (30 patients) underwent simultaneous phalloplasty and radical prostatectomy without lymph node dissection, while Group II patients (30 patients) underwent radical prostatectomy without lymph node dissection. All patients were evaluated during the study: Charlson comorbidity index, International Index of Erectile Function (IIEF-5), anxiety scale (HADS-I), depression scale (HADS-II), SF-36 questionnaire of quality of life, length of the penile, prostate-specific antigen level, as well as registration of nocturnal penile tumescences. The study was conducted at the preoperative stage and 1, 3, 6, and 12 months after surgery. Results. Despite the increase in the duration of surgery in patients of group I, who had a semi-rigid phallus prosthesis installed simultaneously with radical prostatectomy from the penoscrotal approach, there was no statistically significant difference compared to patients of group II (patients who underwent only radical prostatectomy) in terms of the average hospital stay (p = 0.9176), blood loss (p = 0.2938), and average duration of urethral catheter implantation (p = 0.1691). The possibility of maintaining the length of the penis in the postoperative period has been demonstrated in patients after radical prostatectomy, when the phalloplasty prosthesis was installed simultaneously (Group I). The average length of the penis before surgery in group I was 13.04 ± 1.09 cm, and after 12 months, 12.95 ± 1.11 cm (p > 0.05), and in the group without phalloprosthesis, a statistically significant persistent progressive shortening of the average length of the penis (p < 0.05) was detected, while if the average length of the penis before surgery If it was 12.97 ± 1.04cm, then at the annual stage it was only 11.79 ± 1.04 cm (p = 0.0002). The results of the study showed that patients in the single-stage fallaprosthetics group had statistically significantly better results in terms of assessing their psychoemotional state and quality of life compared with patients who underwent only RE: the average anxiety score (HADS-A) group I before surgery was 9.33 ± 1.21 points, after 12 months 4.53 ± 3.19 points (p < 0.05), and in patients of group II, 9.13 ± 1.33 points before surgery, and 9.57 ± 2.45 points a year later. The average depression score (HADS-D) in Group I patients before surgery was 9.03 ± 1.07, and 12 months later it was 4.17 ± 3.07 (p < 0.05), while in Group II patients before surgery it was 8.7 ± 1.29 and 8.77 ± 2.08 after surgery. The average physical health component score (SF-36 PH) was 52.8 ± 1.92 before surgery and 62.7 ± 8.29 12 months after surgery in Group I patients, while it did not change significantly in Group II patients, with a score of 52.7 ± 1.62 before surgery and 52.2 ± 8.02 12 months after surgery. The average score for the psychological component of health (SF-36 MH) in patients of Group I before surgery was 64.43 ± 2.43 points, and by the 12th month of follow-up it was 68.43 ± 7.75 points. In patients of Group II, there was a statistically significant decrease from the preoperative level of 64.1 ± 2.34 points to 61.97 ± 6.61 points after 12 months. Conclusions. One-stage phalloplasty during radical prostatectomy allows for safe and effective surgical treatment of localized prostate cancer and erectile dysfunction, preserving the length of the penis, and significantly improving the quality of life and emotional state of patients in the postoperative period.

  • Open Access

    COMPARATIVE EFFECTIVENESS OF SIMULTANEOUS AND STAGED SURGICAL INTERVENTIONS FOR ERECTILE DYSFUNCTION AND STRESS URINARY INCONTINENCE

    by Andrey I. Bragin-Maltsev, Pavel S. Kyzlasov, Evgeny V. Volokitin, Ali T. Oglu Mustafayev, Evgeniya A. Kameneva, Vladimir V. Pavlenko, Arkady A. Osincev

    Introduction. The evolution of surgical approaches is reflected in a shift toward simultaneous surgeries aimed at addressing multiple clinical issues. Despite the effectiveness of radical prostatectomy in the treatment of prostate cancer, it leads to functional complications (urinary incontinence 1–87%, erectile dysfunction 25–85%), significantly affecting quality of life. The comprehensive correction of these complications remains a priority, as it determines not only physical recovery but also the psychosocial adaptation of patients. Objective. To evaluate the effectiveness of combined surgical correction in the form of a single-stage implantation of a semi-rigid penile prosthesis and a male transobturator sling for the restoration of erectile function and urinary incontinence in patients after radical prostatectomy. Materials and Methods. A prospective analysis of 60 patients with moderate postoperative stress incontinence (77–151 g/24 h according to the Pad test) and severe erectile dysfunction (5 points according to IIEF-5) after radical prostatectomy was performed. The study design included randomization into two groups: Group 1 (two-stage correction, n = 30) – penile prosthesis, 3-month outpatient pause, installation of a male sling; Group 2 (single-stage treatment, n = 30) – single-stage penile prosthesis and installation of a male sling. Diagnostics included determination of PSA, general urine analysis, ultrasound, Pad test, questionnaires according to IIEF-5, ICIQ-SF, I-QoL and HADS (anxiety and depression). Observation was carried out after 1, 3, 4 and 6 months, with an assessment of postoperative changes. Results. Groups 1 and 2 were comparable in age (62.8 ± 3.7 and 62.8 ± 3.7 years), BMI (28.4 ± 2.0 and 27.9 ± 2.0 kg/m²), oncological status (PSA 0.05). The correction was characterized by a statistically shorter duration of the intervention than the sum of the two stages of the operations (83.0 ± 3.2 and 93.8 ± 11.7 min, p = 0.0001) with a comparable safety profile. In Group 2, a more rapid improvement was achieved: normalization of the Pad-test and ICIQ-SF indicators by 1 month versus 4 months in Group 1. Quality of life (I-QoL) in Group 2 improved significantly after 1 month (80.0 ± 4.0% and 57.3 ± 8.8% in Group 1, p <0.05). The psychoemotional state (HADS) in Group 2 normalized by 3 months, while in Group 1 only by 6 months (p = 0.0002). By 6 months, the differences leveled out, achieving a comparable final efficacy. International experience demonstrates the effectiveness of simultaneous surgeries for the correction of erectile dysfunction and incontinence, which is consistent with our results. According to Valenzuela et al. (2019), single-stage correction provides improvement in 93% and 85% of patients, respectively, without increasing the risk of complications. The experience of simultaneous surgeries in Russian urology remains poorly studied. Conclusions. Single-stage correction ensures accelerated rehabilitation with an early improvement in quality of life and psychoemotional status with comparable long-term effectiveness and safety comparable to a two-stage approach.

  • Open Access

    Urinary incontinence and erectile dysfunction are significant adverse outcomes associated with radical prostatectomy in contemporary clinical practice

    by A. I. Bragin-Maltsev, P. S. Kyzlasov, V. A. Perepechay, V. N. Pavlov, R. A. Kazikhinurov, E. V. Volokitin, A. T. Mustafaev, O. A. Isaev

    In recent years, there has been an increase in the number of newly diagnosed cases of prostate cancer (PCa). Radical prostatectomy (RPE) remains the gold standard treatment for localized forms of the disease. With rapid technological advancements, surgical techniques have evolved from the classical RPE to robot-assisted approaches. However, despite improvements in surgical outcomes and reductions in mortality rates associated with PCa, adverse effects such as urinary incontinence and erectile dysfunction remain significant concerns. These complications substantially impact patients' psycho-emotional well-being, leading to increased levels of anxiety and depression, and often necessitate lifestyle modifications characterized by reduced social and daily activity. This study presents a review and analysis of literature sourced from both domestic and international databases, including the Federal Electronic Medical Library, eLIBRARY, and PubMed. The research focused on current data regarding PCa worldwide, as well as urinary incontinence and erectile dysfunction following RPE, and their effects on the psychological health of patients.